Modeling of human GLE1 mutations in mice to understand RNA metabolism in vivo
Description of the granted funding
It has become evident that abnormalities in RNA processing play a fundamental role in multiple human pathologies. This research concentrates on proving new information of biological and pathological functions of multifunctional GLE1 protein, which mediates RNA transport in mammalian cells. I aim at doing this by modeling human GLE1-deficiency, known as lethal congenital contracture syndrome 1 (LCCS1), in mice to facilitate understanding of RNA metabolism in development, physiology, and disease. LCCS1 is a rare embryonic lethal syndrome of the Finnish disease heritage, which causes motoneuron defects but is poorly studied in vivo. The results of my studies tackle not only rare LCCS1 but are also translatable to common diseases with RNA transport contribution, such as Alzheimer's and Parkinson's disease, which are incurable and cause a huge challenge in sustainable health.
Show moreStarting year
2022
End year
2025
Granted funding
Funder
Research Council of Finland
Funding instrument
Postdoctoral Researcher
Decision maker
Scientific Council for Biosciences, Health and the Environment
28.04.2022
28.04.2022
Other information
Funding decision number
348906
Fields of science
Genetics, developmental biology, physiology
Research fields
Kehitysbiologia ja fysiologia
Identified topics
genes, genetics